A TNFR2-Specific TNF Fusion Protein With Improved In Vivo Activity

Tumor necrosis factor (TNF) receptor-2 (TNFR2) has attracted considerable interest as a target for immunotherapy. Indeed, using oligomeric fusion proteins of single chain-encoded TNFR2-specific TNF mutants (scTNF80), expansion of regulatory T cells and therapeutic activity could be demonstrated in v...

Full description

Bibliographic Details
Published in:Frontiers in Immunology
Main Authors: Juan Gamboa Vargas, Jennifer Wagner, Haroon Shaikh, Isabell Lang, Juliane Medler, Mohamed Anany, Tim Steinfatt, Josefina Peña Mosca, Stephanie Haack, Julia Dahlhoff, Maike Büttner-Herold, Carolin Graf, Estibaliz Arellano Viera, Hermann Einsele, Harald Wajant, Andreas Beilhack
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Subjects:
agonist
GvHD
regulatory T cells
serum retention
TNF
TNFR2
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.888274/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.888274/full

Similar Items